Related scientific articles (all)

Percutaneous endoscopic jejunostomy in patients with gastroparesis following lung transplantation: feasibility and clinical outcome.

Authors : Toussaint E, Van Gossum A, Ballarin A, Le Moine O, Estenne M, Knoop C, Devière J, Arvanitakis M
Year : 2012
Journal : Endoscopy
Volume : 44(8)
Pages : 772-5

The landscape of cancer genes and mutational processes in breast cancer.

Authors : Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, + collaborators (among others :, Desmedt C, Sotiriou C, Stratton MR
Year : 2012
Journal : Nature
Volume : 486(7403)
Pages : 400-4

From chemoprevention and organ preservation programs to post-operative management: major achievements and strategies of the EORTC Head & Neck Cancer Group

Authors : Langendijk JA, Licitra L, Psyrri A, Knecht R, Andry G, Fortpied C, Karra Gurunath R
Year : 2012
Journal : EJC Supplements
Volume : 10(1)
Pages : 76-81

Mastocytosis: revisited with new cytogenetic data.

Authors : Vaes M, Vereecken P, de Wind R, Andry G, Li R, Bron D
Year : 2012
Journal : Rev Med Brux
Volume : 33(1)
Pages : 12-21

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

Authors : Burstein HJ, Piccart-Gebhart M, Perez EA, Hortobagyi GN, Wolmark N, Albain KS, Norton L, Winer EP, Hudis CA
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(18)
Pages : 2179-82

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors : Bolla M, Van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, Van Velthoven R, Colombel M, van de Beek C, Verhagen P, Van den Bergh A, Sternberg C, Gasser T, Van Tienhoven G, Scalliet P, Haustermans K, Collette L
Year : 2012
Journal : Lancet
Volume : 380(9858)
Pages : 2018-27

Esophageal self-expanding metallic stent (SEMS) migration: it's a topsy-turvy world.

Authors : Toussaint E, Zalcman M, Devière J, Le Moine O, Arvanitakis M
Year : 2012
Journal : Endoscopy
Volume : 44 Suppl 2
Pages : E352-3

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

Authors : Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, Andre F, Loi S, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(16)
Pages : 1996-2004

Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer - Authors' reply.

Authors : Baselga J, de Azambuja E, Bradbury I, Gelber R
Year : 2012
Journal : Lancet
Volume : 379 (9833)
Pages : 2238

Role of Epac and protein kinase A in thyrotropin-induced gene expression in primary thyrocytes.

Authors : van Staveren WC, Beeckman S, Tomás G, Dom G, Hébrant A, Delys L, Vliem MJ, Trésallet C, Andry G, Franc B, Libert F, Dumont JE, Maenhaut C
Year : 2012
Journal : Exp. Cell Res.
Volume : 318(5)
Pages : 444-52

Bone metastasis in breast cancer: The story of RANK-Ligand.

Authors : Azim HA, Kamal NS
Year : 2012
Journal : J Egypt Natl Canc Inst
Volume : 24(3)
Pages : 107-14

Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.

Authors : Galván I, Ghanem G, Møller AP
Year : 2012
Journal : Bioessays
Volume : 34(7)
Pages : 565-8

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours.

Authors : Schöffski P, Awada A, Dumez H, Gil T, Bartholomeus S, Wolter P, Taton M, Fritsch H, Glomb P, Munzert G
Year : 2012
Journal : Eur. J. Cancer
Volume : 48(2)
Pages : 179-86

Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Authors : Fumagalli D, Andre F, Piccart-Gebhart M, Sotiriou C, Desmedt C
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84 supl 1
Pages : e58-69

Cancer du sein et radiothérapie peropératoire par électrons (IOERT)

Authors : Philippson C, Nogaret JM
Year : 2012
Journal : Gynécologie EMC
Volume : 7(4)
Pages : 1-8

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Authors : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(4)
Pages : 853-859

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors : Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(7)
Pages : 834-42

MDM4 is a key therapeutic target in cutaneous melanoma.

Authors : Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC
Year : 2012
Journal : Nat. Med.
Volume : 18
Pages : 1239-47

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

Authors : Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW
Year : 2012
Journal : J Magn Reson Imaging
Volume : 35(1)
Pages : 166-73

Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).

Authors : Klastersky J, Awada A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 81(1)
Pages : 49-57